Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
RISCHIN, Danny, BIBBY, David C, CHONG, Geoff, KREMMIDIOTIS, Gabriel, LESKE, Annabell F, MATTHEWS, ClaytonA, WONG, ShirleyS, ROSEN, Mark A, DESAI, Jayesh
Published in Clinical cancer research (01.08.2011)
Published in Clinical cancer research (01.08.2011)
Get full text
Journal Article
Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays
Bibby, David C, Savanovic, Michael, Zhang, Jinrong, Torelli, Alessandro, Jeeninga, Rienk E, Gagnon, Luc, Harris, Shannon L
Published in mSphere (23.02.2022)
Published in mSphere (23.02.2022)
Get full text
Journal Article
Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice
Bibby, David C., Talmadge, James E., Dalal, Milind K., Kurz, Scott G., Chytil, Kevin M., Barry, Stephen E., Shand, David G., Steiert, Matthias
Published in International journal of pharmaceutics (11.04.2005)
Published in International journal of pharmaceutics (11.04.2005)
Get full text
Journal Article
In vitro study of GDNF release from biodegradable PLGA microspheres
Aubert-Pouëssel, Anne, Venier-Julienne, Marie-Claire, Clavreul, Anne, Sergent, Michelle, Jollivet, Christophe, Montero-Menei, Claudia N., Garcion, Emmanuel, Bibby, David C., Menei, Philippe, Benoit, Jean-Pierre
Published in Journal of controlled release (24.03.2004)
Published in Journal of controlled release (24.03.2004)
Get full text
Journal Article
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
Pal, Sumanta, Azad, Arun, Bhatia, Shailender, Drabkin, Harry, Costello, Brian, Sarantopoulos, John, Kanesvaran, Ravindran, Lauer, Richard, Starodub, Alexander, Hauke, Ralph, Sweeney, Christopher J, Hahn, Noah M, Sonpavde, Guru, Richey, Stephen, Breen, Timothy, Kremmidiotis, Gabriel, Leske, Annabell, Doolin, Elizabeth, Bibby, David C, Simpson, Jeremy, Iglesias, Jose, Hutson, Thomas
Published in Clinical cancer research (01.08.2015)
Published in Clinical cancer research (01.08.2015)
Get full text
Journal Article
A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
Nowak, Anna K, Brown, Chris, Millward, Michael J, Creaney, Jenette, Byrne, Michael J, Hughes, Brett, Kremmidiotis, Gabriel, Bibby, David C, Leske, Annabell F, Mitchell, Paul L.R, Pavlakis, Nick, Boyer, Michael, Stockler, Martin R
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2013)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2013)
Get full text
Journal Article
A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres
AUBERT-POUËSSEL, Anne, BIBBY, David C, VENIER-JULIENNE, Marie-Claire, HINDRE, Francois, BENOIT, Jean-Pierre
Published in Pharmaceutical research (01.07.2002)
Published in Pharmaceutical research (01.07.2002)
Get full text
Journal Article
Poly(acrylic acid) microspheres containing β-cyclodextrin: loading and in vitro release of two dyes
Bibby, David C, Davies, Nigel M, Tucker, Ian G
Published in International journal of pharmaceutics (05.10.1999)
Published in International journal of pharmaceutics (05.10.1999)
Get full text
Journal Article
Investigations into the structure and composition of β-cyclodextrin/poly(acrylic acid) microspheres
Bibby, David C, Davies, Nigel M, Tucker, Ian G
Published in International journal of pharmaceutics (15.04.1999)
Published in International journal of pharmaceutics (15.04.1999)
Get full text
Journal Article
Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems
Bibby, David C., Davies, Nigel M., Tucker, Ian G.
Published in International Journal of Pharmaceutics (20.03.2000)
Published in International Journal of Pharmaceutics (20.03.2000)
Get full text
Book Review
Journal Article
Abstract 2774: Anti-cancer activity of the tumor-selective, hypoxia-inducing, agent BNC105 in platinum resistant ovarian cancer
Lavranos, Tina C., Leske, Annabell F., Inglis, Daniel J., Brown, Chloe K., Bibby, David C., Kremmidiotis, Gabriel
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Association of baseline IL-8 and ferritin with clinical outcome with everolimus and BNC105P in the DisrupTOR-1 trial
Pal, Sumanta Kumar, Azad, Arun, Bhatia, Sumeet, Drabkin, Harry A., Costello, Brian Addis, Sarantopoulos, John, Kanesvaran, Ravindran, Lauer, Richard C., Sweeney, Christopher, Hahn, Noah M., Sonpavde, Guru, Richey, Stephen Lane, Breen, Timothy, Kremmidiotis, Gabriel, Leske, Annabell F., Doolin, Elizabeth E., Bibby, David C., Simpson, Jeremy Andrew, Iglesias, Jose Luis, Hutson, Thomas E.
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
A phase I/II study of the vascular disrupting agent BNC105P in combination with gemcitabine-carboplatin in partially platinum-sensitive ovarian cancer patients in first or second relapse: An international collaborative group trial of ANZGOG and HOG
Rischin, Danny, Matei, Daniela, Goh, Jeffrey C., Vaughan, Michelle Margaret, Beale, Philip James, Tenney, Meaghan Elizabeth, Martyn, Julie, Sommeijer, Dirkje Willemien, Iglesias, Jose Luis, Bibby, David C., Simpson, Jeremy, Doolin, Elizabeth E., Williams, Corinne E., Stockler, Martin R.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients: Updated phase I results of the Disruptor-1 trial
Sarantopoulos, John, Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Iglesias, Jose Luis, Sonpavde, Guru, Logan, Theodore, Hahn, Noah M., Sweeney, Christopher, Hutson, Thomas E.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Updated phase I results of a phase I/II trial of BNC105P with everolimus in patients with metastatic renal cell carcinoma (mRCC)
Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Sonpavde, Guru, Logan, Theodore, Hahn, Noah M., Sweeney, Christopher, Sarantopoulos, John
Published in Journal of clinical oncology (20.02.2013)
Published in Journal of clinical oncology (20.02.2013)
Get full text
Journal Article
Phase II trial of BNC105P as second-line chemotherapy for advanced malignant pleural mesothelioma (MPM): Australasian Lung Cancer Trials Group and NHMRC Clinical Trials Centre Collaboration
Nowak, Anna K., Brown, Chris, Millward, Michael, Hughes, Brett Gordon Maxwell, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Mitchell, Paul, Pavlakis, Nick, Coskinas, Xanthi, Sebastian, Lucille T, Cummins, Michelle M, Boyer, Michael J., Parnis, Francis, Lavranos, Tina C., Stockler, Martin R.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors
Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Galsky, Matt D., Bylow, Kathryn A., Logan, Theodore, Cowey, Charles Lance, Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Sonpavde, Guru, Hahn, Noah M., Sweeney, Christopher, Sarantopoulos, John
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors (Hoosier Oncology Group)
Hutson, Thomas E., Dang, Long H., Lauer, Richard C., Starodub, Alexander, Hauke, Ralph J., Logan, Theodore, Bylow, Kathryn A., Galsky, Matt D., Bibby, David C., Kremmidiotis, Gabriel, Doolin, Elizabeth E., Lavranos, Tina C., Leske, Annabell F., Hahn, Noah M., Sonpavde, Guru, Sweeney, Christopher, Sarantopoulos, John
Published in Journal of clinical oncology (10.02.2012)
Published in Journal of clinical oncology (10.02.2012)
Get full text
Journal Article